Sundial Growers Inc (SNDL)
0.4499
+0.07 (+17.16%)
USD |
NASDAQ |
May 16, 11:30
Sundial Growers Enterprise Value: 408.90M for May 13, 2022
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 13, 2022 | 408.90M |
May 12, 2022 | 386.44M |
May 11, 2022 | 378.79M |
May 10, 2022 | 447.14M |
May 09, 2022 | 471.76M |
May 06, 2022 | 577.40M |
May 05, 2022 | 602.02M |
May 04, 2022 | 678.50M |
May 03, 2022 | 650.29M |
May 02, 2022 | 644.08M |
April 29, 2022 | 613.01M |
April 28, 2022 | 701.68M |
April 27, 2022 | 751.87M |
April 26, 2022 | 692.82M |
April 25, 2022 | 764.82M |
April 22, 2022 | 732.65M |
April 21, 2022 | 697.35M |
April 20, 2022 | 745.53M |
April 19, 2022 | 818.28M |
April 18, 2022 | 768.66M |
April 14, 2022 | 756.50M |
April 13, 2022 | 905.10M |
April 12, 2022 | 848.33M |
April 11, 2022 | 835.45M |
April 08, 2022 | 827.10M |
Date | Value |
---|---|
April 07, 2022 | 883.39M |
April 06, 2022 | 997.64M |
April 05, 2022 | 1.032B |
April 04, 2022 | 1.093B |
April 01, 2022 | 1.161B |
March 31, 2022 | 1.158B |
March 30, 2022 | 970.93M |
March 29, 2022 | 985.15M |
March 28, 2022 | 1.094B |
March 25, 2022 | 1.164B |
March 24, 2022 | 1.028B |
March 23, 2022 | 739.75M |
March 22, 2022 | 696.07M |
March 21, 2022 | 586.46M |
March 18, 2022 | 566.68M |
March 17, 2022 | 528.97M |
March 16, 2022 | 489.41M |
March 15, 2022 | 462.01M |
March 14, 2022 | 456.45M |
March 11, 2022 | 469.84M |
March 10, 2022 | 515.37M |
March 09, 2022 | 526.91M |
March 08, 2022 | 487.15M |
March 07, 2022 | 463.66M |
March 04, 2022 | 518.26M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
113.88M
Minimum
Oct 30 2020
4.399B
Maximum
Feb 10 2021
642.65M
Average
564.41M
Median
Jan 19 2022
Enterprise Value Benchmarks
Tilray Brands Inc | 2.724B |
Flora Growth Corp | -- |
Aurinia Pharmaceuticals Inc | 1.165B |
Edesa Biotech Inc | 19.60M |
Lexaria Bioscience Corp | 3.060M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -43.63M |
Revenue (Quarterly) | 18.02M |
Total Expenses (Quarterly) | 33.24M |
EPS Diluted (Quarterly) | -0.0159 |
Gross Profit Margin (Quarterly) | -11.00% |
Profit Margin (Quarterly) | -242.0% |
Earnings Yield | -23.86% |
Normalized Earnings Yield | -1.904 |